Skip to content
PubMed This is a summary of 80 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 80 referenced papers

Top Authors

Cinzia Milito
Sapienza University of Rome
Klaus Warnatz
University of Freiburg
Stephen R.A. Jolles
University Hospital of Wales
Francesco Cinetto
University of Padua
Pere Soler‐Palacín
Vall d'Hebron Hospital Universitari
Leif G. Hanitsch
Humboldt-Universität zu Berlin
Bodo Grimbacher
University of Freiburg
Nima Rezaei
Universal Scientific Education and Research Network
Isabella Quinti
Sapienza University of Rome
Hilary J Longhurst
University of Auckland

Top Institutions

Ranked by publications Top 10 institutions

References

References (80)
  1. 1

    Detection of impaired IgG antibody formation facilitates the decision on early immunoglobulin replacement in hypogammaglobulinemic patients.

    Wolf HM, Thon V, Litzman J, Eibl MM

    Frontiers in immunology 2015; (6()):32 doi:10.3389/fimmu.2015.00032.

    PMID: 25699049
  2. 2

    Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference.

    Khemani RG, Smith LS, Zimmerman JJ, et al.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2015; (16(5 Suppl 1)):S23-40 doi:10.1097/PCC.0000000000000432.

    PMID: 26035358
  3. 3

    Comorbidities and assessment of severity of pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference.

    Flori H, Dahmer MK, Sapru A, et al.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2015; (16(5 Suppl 1)):S41-50 doi:10.1097/PCC.0000000000000430.

    PMID: 26035363
  4. 4

    Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence?

    Snijders D, Fernandez Dominguez B, Calgaro S, et al.

    International journal of immunopathology and pharmacology 2015; (28(2)):150-9 doi:10.1177/0394632015584724.

    PMID: 26078380
  5. 5

    Specific Antibody Deficiencies.

    Wall LA, Dimitriades VR, Sorensen RU

    Immunology and allergy clinics of North America 2015; (35(4)):659-70.

    PMID: 26454312
  6. 6

    Pulmonary Manifestations of Primary Immunodeficiency Disorders.

    Nonas S

    Immunology and allergy clinics of North America 2015; (35(4)):753-66.

    PMID: 26454317
  7. 7

    The autoimmune conundrum in common variable immunodeficiency disorders.

    van de Ven AA, Warnatz K

    Current opinion in allergy and clinical immunology 2015; (15(6)):514-24 doi:10.1097/ACI.0000000000000218.

    PMID: 26485099
  8. 8

    How to use immunoglobulin levels in investigating immune deficiencies.

    Ladomenou F, Gaspar B

    Archives of disease in childhood. Education and practice edition 2016; (101(3)):129-35 doi:10.1136/archdischild-2015-309060.

    PMID: 26987724
  9. 9

    [Specific antibody deficiency: Primary immunodeficiency associated to respiratory allergy].

    Fernández F, Campillay R, Palma V, et al.

    Revista chilena de pediatria 2017; (88(2)):252-257 doi:10.1016/j.rchipe.2016.08.006.

    PMID: 27614984
  10. 10

    Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.

    Canessa C, Iacopelli J, Pecoraro A, et al.

    International journal of immunopathology and pharmacology 2017; (30(1)):73-82 doi:10.1177/0394632016681577.

    PMID: 27927705
  11. 11

    Intravenous and subcutaneous immunoglobulin G replacement therapy.

    Bonilla FA

    Allergy and asthma proceedings 2016; (37(6)):426-431 doi:10.2500/aap.2016.37.3987.

    PMID: 27931296
  12. 12

    When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

    Jolles S, Chapel H, Litzman J

    Clinical and experimental immunology 2017; (188(3)):333-341 doi:10.1111/cei.12915.

    PMID: 28000208
  13. 13

    Airway-Clearance Techniques in Children and Adolescents with Chronic Suppurative Lung Disease and Bronchiectasis.

    Lee AL, Button BM, Tannenbaum EL

    Frontiers in pediatrics 2017; (5()):2 doi:10.3389/fped.2017.00002.

    PMID: 28168184
  14. 14

    Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.

    Jolles S, Sánchez-Ramón S, Quinti I, et al.

    Clinical and experimental immunology 2017; (190(2)):226-234 doi:10.1111/cei.13012.

    PMID: 28708268
  15. 15

    Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency.

    Sperlich JM, Grimbacher B, Workman S, et al.

    The journal of allergy and clinical immunology. In practice 2018; (6(1)):159-168.e3 doi:10.1016/j.jaip.2017.05.024.

    PMID: 28734862
  16. 16

    14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency.

    Schepp J, Chou J, Skrabl-Baumgartner A, et al.

    Frontiers in immunology 2017; (8()):964 doi:10.3389/fimmu.2017.00964.

    PMID: 28861081
  17. 17

    Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.

    Pecoraro A, Crescenzi L, Granata F, et al.

    International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.

    PMID: 28898770
  18. 18

    Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).

    Mieves JF, Wittke K, Freitag H, et al.

    Current allergy and asthma reports 2017; (17(11)):78 doi:10.1007/s11882-017-0749-3.

    PMID: 28983790
  19. 19

    Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland.

    Edgar JDM, Richter AG, Huissoon AP, et al.

    Journal of clinical immunology 2018; (38(2)):204-213 doi:10.1007/s10875-017-0469-4.

    PMID: 29423883
  20. 20

    Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.

    Shamriz O, Shadur B, NaserEddin A, et al.

    European journal of pediatrics 2018; (177(8)):1163-1172 doi:10.1007/s00431-018-3171-5.

    PMID: 29777306
  21. 21

    Evaluation of Clinical and Immunological Characteristics of Children with Common Variable Immunodeficiency.

    Alkan G, Keles S, Reisli İ

    International journal of pediatrics 2018; (2018()):3527480 doi:10.1155/2018/3527480.

    PMID: 29849668
  22. 22

    The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

    Baumann U, Routes JM, Soler-Palacín P, Jolles S

    Frontiers in immunology 2018; (9()):1837 doi:10.3389/fimmu.2018.01837.

    PMID: 30147696
  23. 23

    Primary immunodeficiency.

    McCusker C, Upton J, Warrington R

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14(Suppl 2)):61 doi:10.1186/s13223-018-0290-5.

    PMID: 30275850
  24. 24

    Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.

    Wasserman RL

    Immunology and allergy clinics of North America 2019; (39(1)):95-111 doi:10.1016/j.iac.2018.08.001.

    PMID: 30466775
  25. 25

    Loss of ARHGEF1 causes a human primary antibody deficiency.

    Bouafia A, Lofek S, Bruneau J, et al.

    The Journal of clinical investigation 2019; (129(3)):1047-1060.

    PMID: 30521495
  26. 26

    Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.

    Gernez Y, Baker MG, Maglione PJ

    Transfusion 2018; (58 Suppl 3()):3056-3064 doi:10.1111/trf.15020.

    PMID: 30536429
  27. 27

    Comprehensive Genetic Results for Primary Immunodeficiency Disorders in a Highly Consanguineous Population.

    Al-Herz W, Chou J, Delmonte OM, et al.

    Frontiers in immunology 2018; (9()):3146 doi:10.3389/fimmu.2018.03146.

    PMID: 30697212
  28. 28

    ARHGEF1 deficiency reveals Gα13-associated GPCRs are critical regulators of human lymphocyte function.

    Mathew D, Kremer KN, Torres RM

    The Journal of clinical investigation 2019; (129(3)):965-968.

    PMID: 30714991
  29. 29

    EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

    van Dongen JJM, van der Burg M, Kalina T, et al.

    Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.

    PMID: 31263462
  30. 30

    Non-CF Bronchiectasis as a Possible Indicator of a Primary Immunodeficiency: Diagnosis, Clinical Course, and Quality of Life in a Pediatric Cohort.

    Klemann C, Kellermann KB, Ehl S, et al.

    Klinische Padiatrie 2019; (231(5)):240-247 doi:10.1055/a-0963-0293.

    PMID: 31340404
  31. 31

    Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology.

    Chinn IK, Chan AY, Chen K, et al.

    The Journal of allergy and clinical immunology 2020; (145(1)):46-69 doi:10.1016/j.jaci.2019.09.009.

    PMID: 31568798
  32. 32

    Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies.

    Shrestha P, Karmacharya P, Wang Z, et al.

    The World Allergy Organization journal 2019; (12(10)):100068 doi:10.1016/j.waojou.2019.100068.

    PMID: 31641401
  33. 33

    Pulmonary function evaluation in pediatric patients with primary immunodeficiency complicated by bronchiectasis.

    Chiu CC, Wang CJ, Lee WI, et al.

    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2020; (53(6)):1014-1020 doi:10.1016/j.jmii.2020.01.006.

    PMID: 32094076
  34. 34

    An updated review on activated PI3 kinase delta syndrome (APDS).

    Singh A, Joshi V, Jindal AK, et al.

    Genes & diseases 2020; (7(1)):67-74 doi:10.1016/j.gendis.2019.09.015.

    PMID: 32181277
  35. 35

    Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach.

    Wall LA, Wisner EL, Gipson KS, Sorensen RU

    Frontiers in immunology 2020; (11()):522 doi:10.3389/fimmu.2020.00522.

    PMID: 32296433
  36. 36

    Primary Immunodeficiency Disorders in children with Non-Cystic Fibrosis Bronchiectasis.

    Çağdaş D, Pehlivantürk Kizılkan M, Tagiyev A, et al.

    European annals of allergy and clinical immunology 2020; (52(6)):271-276 doi:10.23822/EurAnnACI.1764-1489.151.

    PMID: 32372587
  37. 37

    Evaluation of pulmonary findings in patients with humoral immunodeficiency.

    Karalı Z, Karalı Y, Çekiç Ş, et al.

    Turk pediatri arsivi 2020; (55(2)):174-183 doi:10.14744/TurkPediatriArs.2020.46656.

    PMID: 32684763
  38. 38

    Efficacy and quality of life assessment in the use of subcutaneous immunoglobulin treatment for children with primary immunodeficiency disorder.

    Sarı G, Güven Bilgin B, Yılmaz E, et al.

    European annals of allergy and clinical immunology 2021; (53(4)):177-184 doi:10.23822/EurAnnACI.1764-1489.179.

    PMID: 33191716
  39. 39

    Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.

    Anuradha KWDA, Gunathilaka PKG, Wickramasinghe VP

    Pediatric pulmonology 2021; (56(2)):509-515 doi:10.1002/ppul.25206.

    PMID: 33295693
  40. 40

    Prenatal Diagnosis for Primary Immunodeficiency Disorders-An Overview of the Indian Scenario.

    Yadav RM, Gupta M, Dalvi A, et al.

    Frontiers in immunology 2020; (11()):612316 doi:10.3389/fimmu.2020.612316.

    PMID: 33365035
  41. 41

    Inborn Errors of Immunity: how to diagnose them?

    Grumach AS, Goudouris ES

    Jornal de pediatria 2021; (97 Suppl 1()):S84-S90 doi:10.1016/j.jped.2020.11.007.

    PMID: 33400918
  42. 42

    Update on Infections in Primary Antibody Deficiencies.

    Demirdag YY, Gupta S

    Frontiers in immunology 2021; (12()):634181 doi:10.3389/fimmu.2021.634181.

    PMID: 33643318
  43. 43

    Vaccination in PADs.

    Milito C, Soccodato V, Collalti G, et al.

    Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.

    PMID: 34207916
  44. 44

    COVID-19 in children with inborn errors of immunity: clinical scenarios.

    Moazzen N, Ahanchian H, Aelami MH, et al.

    American journal of clinical and experimental immunology 2021; (10(3)):77-85.

    PMID: 34824897
  45. 45

    Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis.

    Lee E, Sol IS, Kim JD, et al.

    Scientific reports 2021; (11(1)):24287 doi:10.1038/s41598-021-03778-8.

    PMID: 34930997
  46. 46

    Pulmonary manifestations in a cohort of patients with inborn errors of immunity: an 8-year follow-up study.

    Movahedi M, Jamee M, Ghaffaripour H, et al.

    Allergologia et immunopathologia 2022; (50(1)):80-84 doi:10.15586/aei.v50i1.388.

    PMID: 34935317
  47. 47

    The pediatric common variable immunodeficiency - from genetics to therapy: a review.

    Szczawinska-Poplonyk A, Schwartzmann E, Bukowska-Olech E, et al.

    European journal of pediatrics 2022; (181(4)):1371-1383 doi:10.1007/s00431-021-04287-6.

    PMID: 34939152
  48. 48

    Immune Dysregulation in Pediatric Common Variable Immunodeficiency: Implications for the Diagnostic Approach.

    Szczawińska-Popłonyk A, Ta Polska-Jóźwiak K, Schwartzmann E, Popłonyk N

    Frontiers in pediatrics 2022; (10()):855200 doi:10.3389/fped.2022.855200.

    PMID: 35402361
  49. 49

    Impact of Primary Immunodeficiency Diseases on the Life Experiences of Patients in Malaysia From the Caregivers' Perspective: A Qualitative Study.

    Ahmed Meelad R, Abd Hamid IJ, Hashim IF, et al.

    Frontiers in pediatrics 2022; (10()):846393 doi:10.3389/fped.2022.846393.

    PMID: 35433547
  50. 50

    Multiple Breath Washout for Early Assessment of Pulmonary Complications in Patients With Primary Antibody Deficiencies: An Observational Study in Pediatric Age.

    Secchi T, Baselli LA, Russo MC, et al.

    Frontiers in pediatrics 2022; (10()):773751 doi:10.3389/fped.2022.773751.

    PMID: 35656375
  51. 51

    Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations.

    Similuk MN, Yan J, Ghosh R, et al.

    The Journal of allergy and clinical immunology 2022; (150(4)):947-954 doi:10.1016/j.jaci.2022.06.009.

    PMID: 35753512
  52. 52

    Diagnosis of primary immunodeficiency diseases in pediatric patients hospitalized for recurrent, severe, or unusual infections.

    Nepesov S, Firtina S, Aygun FD, et al.

    Allergologia et immunopathologia 2022; (50(4)):50-56 doi:10.15586/aei.v50i4.605.

    PMID: 35789402
  53. 53

    An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency.

    Hashash JG, Squire J, Francis FF, et al.

    The American journal of gastroenterology 2022; (117(11)):1743-1752 doi:10.14309/ajg.0000000000002027.

    PMID: 36148549
  54. 54

    Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms.

    Hanitsch LG

    Current opinion in allergy and clinical immunology 2022; (22(6)):335-342 doi:10.1097/ACI.0000000000000856.

    PMID: 36165423
  55. 55

    Monitoring disease progression in childhood bronchiectasis.

    Ramsey KA, Schultz A

    Frontiers in pediatrics 2022; (10()):1010016 doi:10.3389/fped.2022.1010016.

    PMID: 36186641
  56. 56

    Definition, Incidence, and Epidemiology of Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference.

    Yehya N, Smith L, Thomas NJ, et al.

    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2023; (24(12 Suppl 2)):S87-S98 doi:10.1097/PCC.0000000000003161.

    PMID: 36661438
  57. 57

    Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency.

    Tandon M, DiGiacomo DV, Zhou B, et al.

    Frontiers in immunology 2023; (14()):1217718 doi:10.3389/fimmu.2023.1217718.

    PMID: 37575247
  58. 58

    Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches.

    Tessarin G, Baronio M, Lougaris V

    Current opinion in allergy and clinical immunology 2023; (23(6)):461-466 doi:10.1097/ACI.0000000000000947.

    PMID: 37767915
  59. 59

    Knowledge, awareness, and perception on genetic testing for primary immunodeficiency disease among parents in Malaysia: a qualitative study.

    Ahmad Azahari AHS, Hakim Zada F, Ismail IH, et al.

    Frontiers in immunology 2023; (14()):1308305 doi:10.3389/fimmu.2023.1308305.

    PMID: 38283358
  60. 60

    Multiple-breath washout to detect lung disease in patients with inborn errors of immunity.

    Busack LM, Thee S, Liu Y, et al.

    ERJ open research 2024; (10(2)) doi:10.1183/23120541.01019-2023.

    PMID: 38469376
  61. 61

    A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents.

    Fasshauer M, Schuermann G, Gebert N, et al.

    Immunotherapy 2024; (16(12)):813-819 doi:10.1080/1750743X.2024.2367924.

    PMID: 39073437
  62. 62

    Therapeutic Management of Bronchiectasis in Children and Adolescents: A Concise Narrative Review.

    Faverio P, Franco G, Landoni V, et al.

    Journal of clinical medicine 2024; (13(16)) doi:10.3390/jcm13164757.

    PMID: 39200899
  63. 63

    The lung in inborn errors of immunity.

    Restrepo-Gualteros S, Nino G, Gutierrez MJ

    Pediatric pulmonology 2025; (60 Suppl 1()):S29-S31 doi:10.1002/ppul.27258.

    PMID: 39295479
  64. 64

    [Genetic analysis of a patient with Rod-shaped myopathy due to variants of NEB gene].

    Zheng W, Peng X, Lei Y, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024; (41(12)):1473-1477 doi:10.3760/cma.j.cn511374-20240620-00343.

    PMID: 39653354
  65. 65

    Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia.

    Zech M, Dzinovic I, Skorvanek M, et al.

    Brain : a journal of neurology 2025; (148(8)):2827-2846 doi:10.1093/brain/awaf059.

    PMID: 39937650
  66. 66

    Monogenic Common Variable Immunodeficiency (Mo-CVID) Score for Optimizing the Genetic Diagnosis in Pediatric CVID Cohort.

    Barbati F, Lodi L, Boscia S, et al.

    European journal of immunology 2025; (55(3)):e202451433 doi:10.1002/eji.202451433.

    PMID: 40079712
  67. 67

    A novel truncated mutation in folate receptor α (FRα) affecting its glycosylation and affinity for folate in a consanguineous family with progressive encephalopathy: follow up and treatment improvement.

    Rahma F, Olfa AF, Mahjoub B, et al.

    Molecular biology reports 2025; (52(1)):699 doi:10.1007/s11033-025-10781-z.

    PMID: 40643761
  68. 68

    Radiological Patterns of Pediatric Non-cystic Fibrosis Bronchiectasis: A Retrospective Study From Oman.

    Al Jabri M, Al Humaimi O, Al Yousufi F, et al.

    Cureus 2025; (17(6)):e86516 doi:10.7759/cureus.86516.

    PMID: 40698238
  69. 69

    Non-infectious pulmonary and gastrointestinal manifestations in primary antibody deficiencies: lessons for the clinic.

    Franco M, Buso H, Carfora F, et al.

    Expert review of clinical immunology 2025; (21(9)):1229-1249 doi:10.1080/1744666X.2025.2556435.

    PMID: 40957411
  70. 70

    Immunologic evaluation by a pediatric pulmonologist.

    Manothummetha K, Wyke M, Kleiner G, Gans M

    Paediatric respiratory reviews 2026; (58()):69-82 doi:10.1016/j.prrv.2025.08.002.

    PMID: 40957775
  71. 71

    Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

    Ameratunga R, J Longhurst H, Lehnert K, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.

    PMID: 41324804
  72. 72

    The Relationship Between Peripheral Eosinophilia, Lower Respiratory Tract Pathogens, Age at First Pneumonia, and Malnutrition in Children with Non-cystic Fibrosis Bronchiectasis.

    Olgun EG, Özcan G, Zirek F, et al.

    Thoracic research and practice 2026; (27(2)):96-102 doi:10.4274/ThoracResPract.2026.2025-9-3.

    PMID: 41755496
  73. 73

    Inborn errors of immunity at school: How can we do better?

    Lopez-Seguer L, Rodriguez-Tello S, Gonzalez-Amores M, et al.

    Journal of human immunity 2026; (2(3)):e20250120 doi:10.70962/jhi.20250120.

    PMID: 42170002
  74. 74

    Severe Post-Measles ARDS with Multisystem Complications in an Unvaccinated Child in a Resource-Limited Setting: A Case Report.

    Siyad AO, Hassan AM, Hassan RA

    International medical case reports journal 2026; (19()):608541 doi:10.2147/IMCRJ.S608541.

    PMID: 42220620
  75. 75

    Patient and caregiver perspectives on transition from pediatric to adult care in inborn errors of immunity: a Polish multicenter survey.

    Będzichowska A, Tomaszewska A, Napiórkowska-Baran K, et al.

    Frontiers in immunology 2026; (17()):1816943 doi:10.3389/fimmu.2026.1816943.

    PMID: 42433362
  76. 76

    Bronchiectasis With Inborn Errors of Immunity: Zooming in on Predominantly Antibody Deficiencies.

    Galant-Swafford J, Lommatzsch S, Alam R, Janoff EN

    The journal of allergy and clinical immunology. In practice 2026; (14(9)):2028-2037 doi:10.1016/j.jaip.2026.06.045.

    PMID: 42447990
  77. 77

    Does CVID exist in children? A genetic architecture and manifestation map derived from 7,525 patients.

    Gkantaras A, , Seidel MG

    Journal of human immunity 2026; (2(5)):e20260091 doi:10.70962/jhi.20260091.

    PMID: 42495711
  78. 78

    Work participation in inborn errors of immunity: The dual burden on patients and caregivers.

    Pulvirenti F, Sgrulletti M, Radovic K, et al.

    Journal of human immunity 2026; (2(6)) doi:10.70962/jhi.20260077.

    PMID: 42911122
  79. 79

    Pulmonary Rehabilitation in Inborn Errors of Immunity with Bronchiectasis: A Narrative Review with Implications for High-Consanguinity Settings.

    Alruwaili R, Albelasi A, Alqahtani MM

    Journal of clinical medicine 2026; (15(20)) doi:10.3390/jcm15208131.

    PMID: 42941650
  80. 80

    When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity.

    Aydemir S, Durcan G, Nurhan E, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(11)).

    PMID: 42969273